FDA has approved Lexiscan injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging.

Researchers are on their way of developing new antibiotics from alligator blood that can even beat even drug-resistant superbugs.

Napo Pharmaceuticals announces positive results of a successfully completed Phase 2 trial for CRO-ID conducted by Glenmark Pharmaceuticals.

French drugs research company Servier, whose UK headquarters are at Wexham Springs in Berkshire, has announced that as of 1 April 2008 the arginine salt will replace the tert-butylamine salt of Coversyl and Coversyl Plus. (PRWeb Apr 10, 2008) Read

A pharmaceutical authentication company is now selling equipment which can verify drug ingredients outside of a laboratory. XStream Systems, Inc. offers a unit which can read the molecular structure of medicines without having to open any packaging or break a

IDBS, a provider of drug discovery data management solutions, today announced that the global pharmaceutical company Boehringer Ingelheim (Ingelheim, Germany) has purchased IDBS' predictive modelling technology PredictionBase for use at its Biberach an der Riss research site.Scientists at the Biberach

is a fast-growing, quality provider of packaging services to the pharmaceutical and healthcare industries, and is based in modern, purpose-built premises in a quality environment on the edge of the Brecon Beacons.PACKAGING, STORAGE, DISTRIBUTION AND CLINICAL TRIAL SERVICESBrecon provides the

Enanta Pharmaceuticals presents breakthrough research program to evaluate a new macrolide-related drug class, Bicyclolides, in the treatment of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and other gram-positive infection pathogens.

Abraxis BioScience has announced that the Korean FDA has granted marketing approval for Abraxane for the treatment of breast cancer after failure of standard chemotherapy for metastatic disease.

Over 200 business development and licensing executives from top pharmaceutical and biotech companies gathered at Naples Grande Resort, Florida from March 17-19 to network with potential industry partners and discuss the future trends in drug discovery. (PRWeb Apr 10, 2008)

assisTek, the global leader tablet eDiaries, will be offering demonstrations of the TouchPRO and iPRO platforms at the 17th Annual Partnerships with CROs and Other Outsourcing Providers conference April 14-16 in Las Vegas, NV. (PRWeb Apr 10, 2008) Read the

New regulatory compliance consulting services will help medical device manufacturers and pharmaceutical companies avoid disconnects with their CROs, as well as rapidly increase the turnaround time for obtaining investigational labels. (PRWeb Apr 11, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb846344.htm

Fort Dodge Animal Health offers West Nile-Innovator®+EWT - "The Mosquito Shot," the only vaccine that protects against West Nile virus, EEE and Western Equine Encephalomyelitis, plus tetanus, in one convenient vaccine. (PRWeb Apr 11, 2008) Read the full story at

Mettler Toledo introduces EasyMax™ 102, the new generation automated lab reactor system for the synthesis lab and the synthetic organic chemist. EasyMax™ 102 replaces the traditional oil bath and ice bath, and improves the quality of your experiments. EasyMax™ 102

Creative MediaWorks has recently unveiled an updated website (www.creativemediaworks.com) on Friday, April 11, 2008. The new website more accurately reflects CMW's expanding services and capabilities, has an improved look-and-feel with enhanced graphics, and a new user-friendly page layout. By updating

Future Docs/Pharmacists and Faculty Examine Conflicts of Interest Among Drug Companies and Healthcare Providers (PRWeb Apr 11, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb849064.htm

assisTek, the global leader in electronic tablet electronic patient reported outcomes (ePROs), is proud to announce the iPRO, a new platform for clinical trial patient questionnaires (eDiaries) featuring the Apple iPhone™. (PRWeb Apr 10, 2008) Read the full story at

Regenerative medicine is touted as the next-generation technology to revolutionize the medical system of future. The market for regenerative medicine in bone and joint applications is primarily driven by ageing baby boomer population and escalating incidence of osteoporosis, arthritis, and

TrialStat Issues White Paper on Best Practices for CROs and EDC Vendors; TrialStat to be at Booth 431 at the 17th Annual Partnerships with CROs Conference (PRWeb Apr 10, 2008) Read the full story at http://ww1.prweb.com/releases/2008/04/prweb846824.htm

Oncolytics Biotech has announced encouraging interim results from its UK Reolysin and carboplatin/paclitaxel combination trial for the treatment of head and neck cancer.